StockWatch
·

NITTA GELATIN INDIA LTD.-$

BSE: 506532

P/L Snapshot

Q1 FY27 · standalone

vs Q4 FY26·vs Q1 FY26
Revenue
144.54
-13.2%+2.3%
Expenditure
110.65
-8.1%-4.0%
Net Profit
25.19
-25.9%+30.0%
OPM %
24.46%
-3.60pp+4.66pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
0.0046.6593.29139.94186.58Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Price Chart
Reports

Nitta Gelatin PAT +32% YoY to ₹25.2 Cr on cost relief; revenue flat, -13% QoQ

gelatin · collagen manufacturing · margin expansion

ResultsQ1 FY2731 Jul 20263 minMetals & Mining
Latest
Board Meeting31 Jul, 5:40 pm

Nitta Gelatin PAT +32% YoY to ₹25.2 Cr on cost relief; revenue flat, -13% QoQ

Nitta Gelatin India's consolidated net profit rose 31.6% year-on-year to ₹25.18 Cr in Q1 FY27 (quarter ended 30 June 2026), even as revenue from operations grew just 1.5% YoY to ₹140.87 Cr — making this a margin-led print rather than a volume or pricing story. The operating (EBITDA) margin expanded roughly 466 bps to 24.46% from 19.80% a year ago, and net profit margin rose to 17.42% from 13.54%, as net material cost (cost of materials consumed, adjusted for the inventory-build credit) eased to about 42.1% of revenue from 46.6% in the year-ago quarter — consistent with management's own note that the business's performance is dependent on raw-material quality, availability and price. There were no exceptional items in either this quarter or the year-ago comparator, so the 31.6% YoY PAT growth is a clean, unadjusted number. Standalone PAT of ₹25.19 Cr is nearly identical to the consolidated figure, confirming the small Bamni Proteins subsidiary carries negligible weight on the group result. Sequentially, the picture is softer: revenue fell 12.9% QoQ from Q4 FY26's ₹161.73 Cr and PAT fell 26.2% QoQ from ₹34.09 Cr, with OPM down from 28.06% and NPM down from 20.46%. This looks like a seasonal step-down and mild operating deleverage rather than a fresh cost problem — employee expense rose to 9.65% of revenue (from 7.82% in Q4) and other expenses to 23.80% (from 21.66%) as a broadly fixed cost base sat over a smaller Q1 revenue base, while the net-material-cost ratio itself was little changed QoQ (42.1% vs 42.5%). There is no management guidance or prior concall commentary on record to grade this print against, and no analyst/street coverage was found for this small-cap name, so both vsGuidance and vsStreet are unknown. The remaining quarter-relevant disclosures are governance/legal rather than financial: the board used the same meeting to approve a postal ballot for a KSIDC nominee-director change; Bamni Proteins (shut since a March 2024 Maharashtra Pollution Control Board closure order) stays classified as a discontinued operation with a marginal ₹0.10 Cr loss this quarter while the board explores disposing of its assets on a non-going-concern basis; and the company continues to carry an ₹18.20 Cr contingent liability on a customs-duty/fish-protein import-classification dispute now before the Supreme Court (interim stay granted, final hearing slated for September 2026), with no P&L impact this quarter.

31 Jul 2026, 05:40 pm

Corporate Events

Board MeetingNITTAGELA
2026
31Jul

Board Meeting

The 50th Annual General Meeting of the members of the Compan…

BSE Filing
Board MeetingNITTAGELA
2026
30Jan

Board Meeting

Consider and approve the un-audited financial results (Stand…

BSE Filing
Board MeetingNITTAGELA
2025
31Oct

Board Meeting

Consider and approve un-audited financial results (Standalon…

BSE Filing
Board MeetingNITTAGELA
2025
1Aug

Board Meeting

consider and approve inter-alia the un-audited financial res…

BSE Filing
Board MeetingNITTAGELA
2025
2May

Board Meeting

Consider and approve the standalone and consolidated audited…

BSE Filing
Board MeetingNITTAGELA
2025
10Feb

Board Meeting

consider and approve the un-audited financial results (Stand…

BSE Filing
Board MeetingNITTAGELA
2024
8Nov

Board Meeting

Consider and approve inter-alia the un-audited financial res…

BSE Filing
DividendNITTAGELA
2024
10May

₹6 / share

BSE Filing
Board MeetingNITTAGELA
2024
10May

Board Meeting

Consider and approve the standalone and consolidated audited…

BSE Filing
Board MeetingNITTAGELA
2024
8Feb

Board Meeting

Consideration and approval of Un-Audited Financial Results (…

BSE Filing
Board MeetingNITTAGELA
2023
10Nov

Board Meeting

Consider and approve the unaudited financial results (Standa…

BSE Filing